%A Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou %T Advances in immunotherapy for recurrent and metastatic cervical cancer %0 Journal Article %D 2022 %J Journal of International Oncology %R 10.3760/cma.j.cn371439-20220520-00100 %P 517-520 %V 49 %N 9 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_11183.shtml} %8 2022-09-08 %X

Immunotherapy mainly includes simple immunotherapy (immune checkpoint inhibitor, therapeutic human papillomavirus vaccine, adoptive T cell therapy, double immunotherapy,etc.), immuno-therapy combined with other treatments (such as chemotherapy, antiangiogenic therapy, radiotherapy,etc.). The continuous development of immunotherapy and the improvement of treatment scheme have improved the survival and prognosis of patients, and provided new ideas for the diagnosis and treatment of recurrent and metastatic cervical cancer.

Baidu
map